Vanguard Interm Corp (VCIT) 89.65 $VCIT Global Central

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vanguard Interm Corp (VCIT) 89.65 $VCIT

Global Central Banker’s Expanding QE Supports U.S. Corporate, Treasury ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Mon Aug 08, 3:12PM CDT
With the Bank of England now joining the bond purchasing spree, the additional accommodative measures will likely add further pressure on global borrowing costs, potentially supporting Treasuries and corporate bond exchange traded funds as...
ZROZ: 139.31 (+0.41), VCIT: 89.65 (-0.12), ITR: 34.90 (-0.04), LQD: 123.89 (-0.05), EDV: 140.65 (-0.04), TLT: 139.87 (+0.20)

Why Junk Bond ETFs Are Risky Bets Now
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:32PM CDT
Junk bond ETFs may be on a tear, but this joy ride may hit bumps ahead.
HYG: 86.70 (-0.34), FCOR: 51.39 (-0.07), VCIT: 89.65 (-0.12), LQD: 123.89 (-0.05), VCLT: 96.45 (-0.05)

ECB Buying Spree Helps Lift U.S. Corporate Bond ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jun 08, 3:48PM CDT
Foreign central banks have enacted aggressive bond purchasing programs that have pushed down yields. As foreign investors seek out better returns, U.S. corporate bonds and related exchange traded funds have benefited from their relatively more...
VCIT: 89.65 (-0.12), ITR: 34.90 (-0.04), LQD: 123.89 (-0.05)

May ETF Asset Flow: Gold Wins, EM Loses
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 1:50PM CDT
Inside the assets movements to and from ETFs in the month of May.
EEM: 36.53 (-0.41), TIP: 116.04 (+0.02), VTV: 87.97 (-0.19), SPY: 217.38 (-0.62), QQQ: 116.44 (-0.12), VCIT: 89.65 (-0.12), GLD: 124.78 (-0.25), DIA: 183.94 (-0.57), AGG: 112.57 (-0.02)

Rising Foreign Demand Could Support Corporate Bond ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Fri May 27, 2:45PM CDT
Investment-grade corporate bond exchange traded funds could maintain their momentum on improving fundamentals. Year-to-date, the iShares iBoxx $ Investment Grade Corporate Bond ETF (NYSEArca: LQD) gained 5.8%, Vanguard Intermediate-Term Corporate...
VCIT: 89.65 (-0.12), ITR: 34.90 (-0.04), LQD: 123.89 (-0.05)

20 Hot Intermediate-Term Bond ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Mon May 23, 7:15AM CDT
More investors are dabbling in tactical or alternative fixed-income options in anticipation of a rising interest rate environment or overweighting equities all together. Intermediate-term bonds and the related exchange traded funds still have a place...
LDRI: 25.19 (-0.05), IEI: 126.24 (-0.13), SLQD: 50.93 (-0.01), IEF: 111.77 (-0.13), VCIT: 89.65 (-0.12), ITR: 34.90 (-0.04), SIPE: 19.77 (+0.04), ISTB: 50.62 (-0.01), TIPX: 19.76 (-0.02), BSJI: 25.24 (-0.03), TDTF: 25.31 (-0.03), BSJJ: 24.15 (-0.01), BSJH: 25.94 (+0.01), BIV: 87.70 (-0.06), BSCJ: 21.42 (-0.01), STPZ: 52.39 (-0.04), BSCH: 22.69 (unch), BSCI: 21.36 (+0.02), TDTT: 24.71 (-0.04), CIU: 111.48 (-0.12), CSJ: 105.88 (unch)

28 ETFs for Investment-Grade Corporate Bond Exposure
etftrends@etftrends.com (ETF Trends) - ETF Trends - Wed May 11, 4:15PM CDT
Bond investors who are wary of dipping too far into junk bond territory but want better yield payouts than Treasuries may consider investment-grade corporate bond exchange traded funds. Currently, credit spreads are falling. Looking at corporate...
LDRI: 25.19 (-0.05), SLQD: 50.93 (-0.01), VCIT: 89.65 (-0.12), SCPB: 30.77 (-0.02), VCSH: 80.71 (-0.03), MINC: 48.90 (-0.04), IGIH: 23.77 (-0.20), FCOR: 51.39 (-0.07), LQDH: 92.66 (-0.06), CLY: 64.14 (+0.02), LWC: 43.40 (unch), QLTA: 53.96 (-0.04), CSJ: 105.88 (unch), PFIG: 26.03 (-0.04), ITR: 34.90 (-0.04), SKOR: 52.07 (+0.04), VCLT: 96.45 (-0.05), IGHG: 74.04 (-0.05), FLTB: 50.98 (+0.08), CLYH: 24.04 (-0.06), CBND: 33.07 (-0.08), LQD: 123.89 (-0.05), CORP: 107.35 (-0.07), IGU: 69.00 (+0.51), CIU: 111.48 (-0.12), RAVI: 75.61 (+0.05), IGS: 25.29 (-0.06)

ETF TMI: Equity ETFs, Millennials and Turkey
etftrends@etftrends.com (ETF Trends) - ETF Trends - Thu May 05, 5:57PM CDT
Got a case of TMI (Too Much Information)? ETF Trends takes a condensed look at latest happenings… The Day’s Hot News In Equity ETFs Markets saw what appeared to be a rotation in U.S. equities and fixed income names. Both SPDR S&P Dividend...
TUR: 37.97 (-0.19), JNK: 36.54 (-0.18), TIP: 116.04 (+0.02), HYG: 86.70 (-0.34), IWD: 106.39 (-0.32), IFGL: 30.16 (-0.04), VCIT: 89.65 (-0.12), IPE: 57.93 (-0.01), REM: 10.74 (+0.01), IWM: 123.23 (-0.70), IWF: 104.18 (-0.20), SDY: 85.66 (-0.29)

Bond ETF Strategy for a Rising Rate Environment
ETFtrends.com - ETF Trends - Thu Nov 12, 4:00PM CST
As the markets prepare for a rising interest rate environment, bond exchange traded fund investors may turn to more defensive strategies to prop up performance and mitigate rate risks. Charles Schwab strategists argue that fixed income will offer...
ULST: 40.22 (+0.01), FLRN: 30.55 (unch), NEAR: 50.21 (unch), FLOT: 50.74 (+0.03), FLTR: 24.93 (+0.03), ITM: 24.78 (+0.01), IEF: 111.77 (-0.13), VCIT: 89.65 (-0.12), ITR: 34.90 (-0.04), MUB: 113.60 (-0.03), TFI: 50.52 (+0.02), BSV: 80.78 (-0.01), LQD: 123.89 (-0.05), SHY: 84.98 (-0.01), SCHR: 55.43 (-0.03), GSY: 50.16 (unch), VGIT: 66.57 (-0.05), MINT: 101.45 (+0.03)

ETFs To Play While Inflation Is Flat
ETFtrends.com - ETF Trends - Tue Oct 13, 3:50PM CDT
While the U.S. is stuck with an anemic inflation rate, investors can ride out a deflationary environment through certain assets and exchange traded funds. According to the Bureau of Labor Statistics, the total national rate of inflation was 0.2% in...
IEF: 111.77 (-0.13), ITR: 34.90 (-0.04), VCIT: 89.65 (-0.12), MUB: 113.60 (-0.03), VIG: 85.16 (-0.14), TFI: 50.52 (+0.02), SCHD: 42.48 (-0.08), USDU: 26.35 (+0.01), UUP: 24.82 (-0.01), NOBL: 55.35 (-0.20), LQD: 123.89 (-0.05), SCHR: 55.43 (-0.03), VGIT: 66.57 (-0.05), SDY: 85.66 (-0.29)

BUYINS.NET: VCIT, VCSH, CXDC, CCM, UBT, RLD Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Sep 22, 10:42AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Vanguard Intermediate Term Corporate Bond ETF (NASDAQ:VCIT), Vanguard Scottsdale Funds Short Term Corporate Bond Etf (NASDAQ:VCSH), China XD Plastics Company Ltd (NASDAQ:CXDC), Canarc Resource Corp (NYSE:CCM), ProShares Ultra 20+ Year Treasury (NYSE:UBT), RealD Inc (NYSE:RLD) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CXDC: 4.88 (-0.12), CCM: 4.24 (+0.01), RLD: 11.00 (+0.02), VCIT: 89.65 (-0.12), UBT: 99.61 (+0.05), VCSH: 80.71 (-0.03)

Areas That Fixed-Income ETF Investors Should Keep An Eye On
ETFtrends.com - ETF Trends - Thu Sep 10, 2:46PM CDT
Despite the elevated volatility as a result of slowing economic growth and uncertainty over the Federal Reserve rate hike, investors may still find value in some fixed-income assets and related exchange traded funds. For instance, Russ Koesterich,...
JNK: 36.54 (-0.18), TIP: 116.04 (+0.02), HYG: 86.70 (-0.34), ITM: 24.78 (+0.01), VCIT: 89.65 (-0.12), MUB: 113.60 (-0.03), LQD: 123.89 (-0.05), TFI: 50.52 (+0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Flora Growth Corp Sees 6% Surge in After-Hours Performance

Updated Category News Views 87

A Surge in After-Hours Trading for Flora Growth Corp Flora Growth Corp. (NASDAQ: FLGC) recently demonstrated significant volatility by surging 5.98% to $10.55 during after-hours trading. This movement came not long after closing at $9.96, which marked an increase of 3.59% earlier that day. Insights from Recent SEC Filing Regulation A Filing In a notable move, Flora Growth...

Continue Reading
Qubs Introduces Qubitunes, A New Interactive Audio Experience

Updated Category News Views 205

Qubs Launches Qubitunes for Creative Play Qubs has unveiled an exciting new product, Qubitunes, which has already won the 'Top Toy' award in the startup category at a prestigious Toy Fair. This innovative toy is set to transform playtime for children by offering a unique platform where they can express their creativity and dive into their own audio storytelling...

Continue Reading
Asyad Group's Expert Transport of Heavy Cryogenic Tank

Updated Category News Views 126

Asyad Group's Successful Transport of Cryogenic Tank Asyad Group has recently completed a remarkable international transport operation, successfully moving a 115 metric ton pressurized cryogenic tank from Northern India to a major destination in Saudi Arabia. This endeavor highlights the Group's expertise in cross-border logistics. A Journey of Precision The transport...

Continue Reading
Famous Toastery Launches Holiday Fundraising Efforts

Updated Category News Views 134

Famous Toastery's Compassionate Campaign for Local Communities The Famous Toastery, known for its delightful breakfast and brunch offerings, is stepping up this holiday season with a noble initiative aimed at fighting hunger. This renowned franchise is collaborating with Feeding the Carolinas, encouraging guests to make donations that will significantly impact individuals...

Continue Reading
Jiayin Group's Upcoming Earnings Call Set for November 25, 2025

Updated Category News Views 190

Jiayin Group Inc. Announces Q3 2025 Financial Results Release Jiayin Group Inc. (NASDAQ: JFIN), a prominent fintech platform in China, has shared significant news that it will unveil its unaudited financial outcomes for the third quarter of 2025. This crucial announcement is set to occur before the U.S. markets open on November 25, 2025. The anticipation surrounding these...

Continue Reading